CClinicalTrials.gg
Not yet recruitingNCT07351994ANfiELDUpdated Jan 20, 2026

Autonomic Neural Field Block for Visceral Pain in Minimally Invasive Left-Sided Colectomy

An observational study in Postoperative Pain, Postoperative Nausea and Opioid Use, sponsored by Antonio Caycedo, MD. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-20.

Sponsored by Antonio Caycedo, MD · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
400
Ages
18 Years and older
Sex
All
01

Study summary

Effective postoperative pain control is a core component of enhanced recovery after surgery (ERAS) pathways in colorectal surgery; however, postoperative pain following minimally invasive left-sided colectomy remains a persistent clinical challenge. Standard multimodal analgesic strategies primarily target somatic pain pathways and may inadequately address visceral postoperative pain, which is mediated through autonomic afferent neural pathways. Residual visceral pain is associated with increased opioid consumption, postoperative nausea and vomiting, delayed recovery, and prolonged length of stay.

This prospective, multicenter observational registry evaluates the feasibility and real-world outcomes of an intraoperative autonomic neural field block targeting the superior hypogastric and inferior mesenteric plexuses during minimally invasive left-sided colectomy. The technique is performed under direct visualization as an adjunct to standard ERAS-based analgesic care. The primary outcome is postoperative opioid consumption within the first 24 hours after surgery. Secondary outcomes include opioid use through 48 hours, postoperative nausea and vomiting, antiemetic use, pain scores, length of stay, and readiness for discharge. Data from this registry will inform future comparative studies and help define the role of autonomic neural modulation in perioperative pain management for colorectal surgery.

Read the detailed description

Background and Rationale

Effective postoperative pain control is a cornerstone of enhanced recovery after surgery (ERAS) pathways in colorectal surgery. Adequate analgesia facilitates early mobilization, pulmonary hygiene, gastrointestinal recovery, and timely hospital discharge. Despite widespread adoption of ERAS protocols and multimodal, opioid-sparing analgesic strategies, postoperative pain following left-sided colectomy remains a clinically relevant and persistent challenge. A substantial proportion of patients continue to experience moderate to severe pain in the early postoperative period, which may contribute to increased opioid consumption, postoperative nausea and vomiting (PONV), delayed functional recovery, and prolonged length of stay.

Current perioperative analgesic approaches in colorectal surgery predominantly address somatic pain pathways. These strategies include non-opioid analgesics, opioid-based regimens, local anesthetic infiltration, neuraxial techniques, and transversus abdominis plane (TAP) blocks. While effective in reducing abdominal wall and incisional pain, these modalities do not specifically target visceral postoperative pain, which is mediated through autonomic afferent neural pathways. Visceral pain arises from bowel distension, traction, ischemia, and inflammatory processes affecting the colon and mesentery and is transmitted primarily via sympathetic and parasympathetic fibers. This component of postoperative pain is qualitatively distinct, often diffuse and poorly localized, and frequently associated with nausea, ileus, and other autonomic symptoms.

Neuraxial techniques may provide effective visceral analgesia but are invasive, resource-intensive, and associated with potential adverse effects such as hypotension and urinary retention. As a result, many contemporary ERAS pathways have moved away from routine neuraxial analgesia, creating an unmet need for effective, targeted visceral pain control that is compatible with minimally invasive surgical workflows and ERAS principles.

Targeted modulation of autonomic neural pathways involved in visceral afferent transmission represents a potential strategy to address this gap. The superior hypogastric plexus and inferior mesenteric plexus play central roles in transmitting visceral sensory input from the left colon and rectum and are anatomically consistent structures routinely encountered during left-sided colorectal resection. Intraoperative autonomic neural field block targeting these plexuses may offer a mechanistically distinct approach to perioperative analgesia that complements existing somatic-focused techniques.

Description of the Intervention

The autonomic neural field block is performed intraoperatively during elective minimally invasive (laparoscopic or robotic) left-sided colonic or rectal resection with primary anastomosis constructed above the peritoneal reflection. Following establishment of pneumoperitoneum and trocar placement according to surgeon preference, standard minimally invasive dissection is carried out.

Dissection exposes the inferior mesenteric plexus in proximity to the origin of the inferior mesenteric artery and the superior hypogastric plexus at the level of the sacral promontory. These anatomic landmarks are routinely visualized during left-sided colorectal surgery and do not require additional dissection beyond standard operative technique.

An insulin needle connected to an anesthesia extension set is introduced through a 10-12 mm auxiliary port and attached to a syringe containing a diluted local anesthetic solution. All air is purged from the system prior to injection. Each plexus is infiltrated with approximately 5-7 mL of local anesthetic solution, administered incrementally in 1 mL aliquots. Aspiration is performed prior to each injection to confirm the absence of intravascular placement, and adequate tissue infiltration is confirmed visually. The surgical procedure then proceeds according to standard operative practice. When an extraction incision is used, any remaining local anesthetic solution may be infiltrated into the incision prior to closure.

Perioperative Analgesic Management

The autonomic neural field block is intended to complement, rather than replace, established multimodal perioperative analgesic strategies. Additional analgesic interventions, including TAP blocks, non-opioid medications, and opioid administration, are performed according to institutional ERAS protocols and surgeon or anesthesiologist discretion. This pragmatic approach allows evaluation of autonomic neural blockade within real-world clinical environments and across varying perioperative practices.

Study Design and Registry Framework

This study is a prospective, multicenter observational registry designed to systematically collect perioperative analgesic and recovery outcomes in patients undergoing minimally invasive left-sided colectomy who receive an intraoperative autonomic neural field block. The registry is descriptive and hypothesis-generating and does not mandate a comparator group. Use of additional analgesic modalities, including TAP block, is recorded but not standardized.

Participating centers collect perioperative data using standardized case report forms. Data capture includes patient demographics, operative details, analgesic interventions, and postoperative recovery metrics. The registry is designed to facilitate assessment of feasibility, reproducibility, and variability of outcomes across institutions and practice settings.

Outcome Measures

The primary outcome is postoperative opioid consumption, expressed as morphine milligram equivalents (MME), during the first 24 hours following surgery. Secondary outcomes include cumulative opioid consumption during the first 48 postoperative hours, intraoperative analgesic requirements, incidence of postoperative nausea and vomiting, antiemetic use, length of hospital stay, and readiness for discharge based on ERAS-aligned criteria. Patient-reported pain outcomes are collected during hospitalization and through the first postoperative week after discharge.

Safety and Feasibility

Feasibility outcomes include the ability to perform the autonomic neural field block under direct visualization without deviation from standard operative technique or prolongation of operative time. Adverse events potentially related to the intervention, including bleeding, vascular injury, or hemodynamic instability temporally associated with the block, are recorded. The registry does not alter routine postoperative monitoring or follow-up.

Data Analysis and Future Directions

Data from this registry will be summarized using descriptive statistics. The registry is not powered to assess comparative efficacy but is intended to generate preliminary data regarding analgesic patterns, recovery trajectories, and variability across centers. These findings will inform the design of future comparative or randomized studies, refine patient selection, and help define the role of autonomic neural modulation within ERAS-aligned perioperative pain management strategies for colorectal surgery.

02

Conditions studied

  • Postoperative Pain
  • Postoperative Nausea
  • Opioid Use
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's planned enrollment of 400 is above the median of 102 across 608 observational studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

This is the only study on the registry with Antonio Caycedo, MD as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population includes adult patients undergoing elective minimally invasive (laparoscopic or robotic) left-sided colonic or rectal resection with primary anastomosis constructed above the peritoneal reflection. Eligible patients receive an intraoperative autonomic neural field block targeting the superior hypogastric and/or inferior mesenteric plexuses under direct visualization as part of routine operative care. Perioperative management follows institutional standardized analgesic pathways, such as enhanced recovery after surgery (ERAS) protocols, with postoperative opioid administration documented in the medical record. Patients undergoing emergency surgery, procedures without primary anastomosis, low pelvic or extraperitoneal anastomoses, planned open surgery, or those with contraindications to local anesthetics are excluded.

Inclusion criteria

  • Age ≥ 18 years.
  • Scheduled for elective minimally invasive (laparoscopic or robotic) left-sided colonic or rectal resection with primary anastomosis constructed above the peritoneal reflection (e.g., sigmoid colectomy, left colectomy, anterior resection/rectosigmoid resection with intraperitoneal anastomosis).
  • Planned intraoperative administration of autonomic neural field block targeting the superior hypogastric plexus and/or inferior mesenteric plexus, performed under direct visualization, as part of routine operative workflow.
  • Managed perioperatively under an institutional standard analgesic pathway (e.g., ERAS or equivalent), with postoperative opioid administration recorded in the medical record.
  • Ability to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Emergency/urgent colorectal surgery (e.g., perforation, uncontrolled bleeding, toxic megacolon, obstructing cancer requiring urgent operation).
  • Planned open left-sided colectomy/rectal resection (minimally invasive approach not intended).
  • Procedures in which no primary anastomosis is created (e.g., Hartmann's procedure, end colostomy, permanent diversion without anastomosis).
  • Planned low pelvic/extra-peritoneal anastomosis (e.g., low anterior resection with anastomosis at or below the peritoneal reflection) or planned handsewn coloanal anastomosis.
  • Known allergy or contraindication to the local anesthetic agents used for the block (or inability to receive local anesthetic for clinical reasons).
  • Inability to reliably capture outcome data for the primary endpoint (e.g., anticipated transfer to another facility within 24 hours post-op, incomplete medication administration records).
  • Pregnancy
  • Prisoners or other protected populations where participation is restricted
  • Chronic opioid therapy at baseline defined as daily opioid use for > 30 days preoperatively, or baseline opioid dose > 30 MME/day
  • Planned use of neuraxial analgesia (epidural/spinal) intended for postoperative analgesia
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
400 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Autonomic Neural Field Block Cohort

    This cohort includes adult patients undergoing elective minimally invasive (laparoscopic or robotic) left-sided colonic or rectal resection with primary anastomosis who receive an intraoperative autonomic neural field block targeting the superior hypogastric and inferior mesenteric plexuses. The autonomic neural field block is performed under direct visualization as an adjunct to standard perioperative care within established enhanced recovery after surgery (ERAS) pathways. Use of additional analgesic modalities, including transversus abdominis plane blocks, non-opioid analgesics, and opioids, is permitted according to institutional practice and is recorded as part of routine perioperative management.

    Procedure: Autonomic Neural Field Block

Interventions

  • ProcedureAutonomic Neural Field Block

    An intraoperative autonomic neural field block targeting the superior hypogastric and inferior mesenteric plexuses is performed under direct visualization during elective minimally invasive left-sided colorectal resection. The block is administered using incremental injections of diluted local anesthetic as an adjunct to standard perioperative analgesic care within established enhanced recovery after surgery (ERAS) pathways.

    Also known as: Neural blockade

06

What researchers measure

Primary outcomes

  1. Opiod consumption

    Total opioid consumption during the first 24 hours following surgery, converted to morphine milligram equivalents (MME), based on all opioid medications administered during the postoperative period.

    Time frame: 24 hours

Secondary outcomes

  1. Postoperative opioid consumption (48 hours)

    Total cumulative opioid consumption during the first 48 hours following surgery, converted to morphine milligram equivalents (MME), based on all opioid medications administered postoperatively

    Time frame: 48 hours

  2. Intraoperative opioid administration

    Total opioid dose administered intraoperatively, converted to morphine milligram equivalents (MME), as recorded in the anesthesia record.

    Time frame: Intraoperative period

  3. Postoperative nausea and vomiting (PONV)

    Incidence of postoperative nausea and/or vomiting documented during the postoperative period and/or requirement for antiemetic medication.

    Time frame: First 48 hours after surgery

  4. Antiemetic medication use

    Administration of any antiemetic medication during the postoperative period, recorded as a binary outcome and by total number of doses administered.

    Time frame: First 48 hours after surgery

  5. Postoperative pain intensity

    Patient-reported pain intensity measured using a standardized numeric rating scale (0-10) at predefined postoperative time points.

    Time frame: Postoperative days 0-7

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Daes J, Morrell DJ, Hanssen A, Caballero M, Luque E, Pantoja R, Luquetta J, Pauli EM. Paragastric Autonomic Neural Blockade to Prevent Early Visceral Pain and Associated Symptoms After Laparoscopic Sleeve Gastrectomy: a Randomized Clinical Trial. Obes Surg. 2022 Nov;32(11):3551-3560. doi: 10.1007/s11695-022-06257-9. Epub 2022 Sep 2. PubMed 36050617 ↗
  • Caycedo-Marulanda A, Sanchez A, Ferrara M, Daes J. Intraoperative autonomic field block combined with the transversus abdominis plane block: for left-sided colectomies (video forum). Tech Coloproctol. 2025 May 21;29(1):117. doi: 10.1007/s10151-025-03154-y. No abstract available. PubMed 40397141 ↗

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Sap, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07351994
Lead sponsor
Antonio Caycedo, MD
Responsible party
Antonio Caycedo, MD (Chief of Colorectal Surgery, Orlando Health, Inc.) — Sponsor-investigator
First posted
Jan 20, 2026
Start date
Jan 20, 2026 (estimated)
Primary completion
Jul 20, 2026 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Jan 20, 2026

Study contacts

Caycedo, MD. MSc
Contact
antonio.caycedo@orlandohealth.com
3218433864
Broome
Contact
barbara.broome@orlandohealth.com
3218433864
Antonio Caycedo, MD, MSc
principal investigator · Orlando Health Colon & Rectal Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion